#MSVirtual2020 – Lesions First Seen on Nerves of GI Tract in Mouse Model of MS

Before signs of neurodegeneration in the brain and spinal cord are evident in mice with experimental autoimmune encephalomyelitis (EAE) — which resembles human multiple sclerosis (MS) — signs can first be found in the network of nerves innervating the gastrointestinal (GI) tract, a study reports.

Additional research is needed to confirm these findings, its investigators stressed.

Still, these results add to the growing body of literature supporting the importance of this network of GI nerves in the onset and development of neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s, and Alzheimer’s disease as well as MS.

Findings were detailed at MSVirtual2020 by Stefanie Kürten, MD, PhD, with the Institute of Anatomy and Cell Biology at Friedrich-Alexander University Erlangen-Nürnberg in the oral presentation, “The Enteric Nervous System as a Potential Autoimmune Target in Multiple Sclerosis.”

In MS, the fatty sheath of myelin protecting nerve endings is gradually destroyed by the immune system, leading to the formation of lesions in the central nervous system (CNS; the brain and spinal cord).

However, more than 60% of MS patients report experiencing GI problems, and more than 30% claim these symptoms start before the onset of the disease itself, challenging the notion that MS is restricted to the CNS.

When these investigators examined portions of the colon taken from MS patients during surgery, they found evidence of local inflammation and neurodegeneration in the nerves forming the myenteric plexus, similar to what they had seen in the mice.

“Our current working hypothesis is that in the context of … EAE you will have the formation of both MBP and PLP specific antibodies. These antibodies then go on to bind to not only to the CNS, but also to the ENS … and as a result the ENS will degenerate,” Kürten said.

Additional studies are needed to confirm if neurodegeneration truly occurs in the ENS before appearing in the CNS, Kürten said.

However, “this is very difficult to do in MS patients themselves. We are going to use our [mouse] model to address this question,” she added.

The team is also examining samples from MS patients to determine if different types of neurons found in the ENS may be targeted and affected by these self-reactive antibodies differently.

Studies are also underway to “address the question whether there are cross-reactivity with foreign antigens [molecules able to induce an immune response], in particular with food components, and antigens of the central nervous system and the enteric nervous system,” Kürten said.

Here, Kürten emphasized a particular ongoing project in which the team is analyzing the role of cow milk in MS. A previous study suggested a correlation between the consumption of liquid cow milk (as opposed to dairy products like cheese) and MS prevalence.

The team believes there might be cross-reactivity between cow milk’s protein casein and different myelin antigens present in both the CNS and ENS, potentially aggravating symptoms in MS patients who consume unprocessed cow milk.